Millipore Sigma Vibrant Logo

422000 Kenpaullone - CAS 142273-20-9 - Calbiochem

A potent, cell-permeable, and reversible inhibitor of glycogen synthase kinase-3β (IC₅₀ = 230 nM), Lck (IC₅₀ = 470 nM), and cyclin-dependent kinases (Cdks).

Kenpaullone - CAS 142273-20-9 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: 9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one, NSC-664704

Primary Target: Gsk-3β
View Products on Sigmaaldrich.com
422000
查看价格及供货情况

概述

Replacement Information

重要规格表

CAS #Empirical Formula
142273-20-9C₁₆H₁₁BrN₂O

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
422000-1MGCN
正在查询供货情况......
—
目前缺货 目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余：另行通知
      其余：另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      		 塑胶安瓿;塑胶针药瓶 1 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      —
      Request Pricing
      		 —
      Description
      OverviewA potent, cell-permeable, and reversible inhibitor of glycogen synthase kinase-3β (IC50 = 230 nM), Lck (IC50 = 470 nM), and cyclin-dependent kinases (Cdks). Inhibits Cdk1/cyclin B (IC50 = 400 nM), Cdk2/cyclin A (IC50 = 680 nM), Cdk2/cyclin E (IC50 = 7.5 µM), and Cdk5/p25 (IC50 = 850 nM). Also inhibits other kinases such as c-Src (IC50 = 15 µM), casein kinase II (IC50 = 20 µM), ERK1 (IC50 = 20 µM), and ERK2 (IC50 = 9 µM). Inhibition is competitive with respect to ATP binding.
      Catalogue Number422000
      Brand Family Calbiochem®
      Synonyms9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one, NSC-664704
      References
      ReferencesBain, J., et al. 2003. Biochem. J. 371, 199.
      Buolamwini, J.K. 2000. Curr. Pharm. Des. 6, 379.
      Schultz, C., et al. 1999. J. Med. Chem. 42, 2909.
      Zaharevitz, D.W., et al. 1999. Cancer Res. 59, 2566.
      Product Information
      CAS number142273-20-9
      ATP CompetitiveY
      FormYellow-brown solid
      Hill FormulaC₁₆H₁₁BrN₂O
      Chemical formulaC₁₆H₁₁BrN₂O
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetGsk-3β
      Primary Target IC<sub>50</sub>230 nM, 470 nM, 400 nM, 680 nM, 7.5 µM, 850 nM, 15 µM, 20 µM, 20 µM, 9 µM against glycogen synthase kinase-3β, Lck IC50, Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, and Cdk5/p25, c-Src, casein kinase II, ERK1, and ERK2
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      422000-1MGCN 04055977187137

      Documentation

      Kenpaullone - CAS 142273-20-9 - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      Kenpaullone - CAS 142273-20-9 - Calbiochem 分析证书

      标题批号
      422000

      参考

      参考信息概述
      Bain, J., et al. 2003. Biochem. J. 371, 199.
      Buolamwini, J.K. 2000. Curr. Pharm. Des. 6, 379.
      Schultz, C., et al. 1999. J. Med. Chem. 42, 2909.
      Zaharevitz, D.W., et al. 1999. Cancer Res. 59, 2566.

      小册子

      标题
      Alzheimer's Disease Brochure & Technical Guide
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-December-2009 RFH
      Synonyms9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one, NSC-664704
      DescriptionA potent cell-permeable and reversible inhibitor of glycogen synthase kinase-3β (IC50 = 230 nM), Lck (IC50 = 470 nM), and cyclin-dependent kinases (Cdks). Inhibits Cdk1/cyclin B (IC50 = 400 nM), Cdk2/cyclin A (IC50 = 680 nM), Cdk2/cyclin E (IC50 = 7.5 µM), and Cdk5/p25 (IC50 = 850 nM). Also inhibits other kinases such as c-Src (IC50 = 15 µM), casein kinase II (IC50 = 20 µM), ERK1 (IC50 = 20 µM), and ERK2 (IC50 = 9 µM). Inhibition is competitive with respect to ATP binding.
      FormYellow-brown solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number142273-20-9
      Chemical formulaC₁₆H₁₁BrN₂O
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBain, J., et al. 2003. Biochem. J. 371, 199.
      Buolamwini, J.K. 2000. Curr. Pharm. Des. 6, 379.
      Schultz, C., et al. 1999. J. Med. Chem. 42, 2909.
      Zaharevitz, D.W., et al. 1999. Cancer Res. 59, 2566.